Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia

Journal of Clinical Biochemistry and Nutrition

Volumn 52, Issue 1, 2013, Pages 82-88

  Toshikuni, Nobuyuki ^a   Fukumura, Atsushi ^a   Hayashi, Nobuhiko ^a   Nomura, Tomoe ^a   Tsuchishima, Mutsumi ^a   Arisawa, Tomiysu ^a   Tsutsumi, Mikihiro ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Alcoholic fatty liver; Diabetes mellitus; Dyslipidemia; Hypertension; Nonalcoholic fatty liver

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ALCOHOLIC FATTY LIVER; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; JAPANESE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER;

EID: 84872301200     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.12-55     Document Type: Article

References (23)

1. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010; 55: 560-578.
2. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011; 141: 1572-1585.
3. Mills SJ, Harrison SA. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Curr Gastroenterol Rep 2005; 7: 32-36.
4. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285.
5. Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-728.
6. Moore JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proc Nutr Soc 2010; 69: 211-220.
7. Okanoue T, Umemura A, Yasui K, Itoh Y. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol 2011; 26 (Suppl 1): 153-162.
8. Nakanishi N, Yoshida H, Nakamura K, Suzuki K, Tatara K. Alcohol consumption and risk for hypertension in middle-aged Japanese men. J Hypertens 2001; 19: 851-855. (Pubitemid 32436947)
9. Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA. Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich) 2005; 7: 346-351.
10. Seike N, Noda M, Kadowaki T. Alcohol consumption and risk of type 2 diabetes mellitus in Japanese: a systematic review. Asia Pac J Clin Nutr 2008; 17: 545-551.
11. Van de Wiel A. The effect of alcohol on postprandial and fasting triglycerides. Int J Vasc Med 2012; 2012: 862504.
12. Takada A, Tsutsumi M. Diagnostic criteria for alcoholic liver disease. Int Hepatol Comm 1995; 3: 63-69.
13. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Nonalcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007; 22: 778-787. (Pubitemid 46915352)
14. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
15. Kuzuya T, Nakagawa S, Satoh J, et al. Report of the Committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus. J Japan Diab Soc 1999; 42: 385-404 (in Japanese with English abstract).
16. Teramoto T, Sasaki J, Ueshima H, et al. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007; 14: 155-158.
17. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002; 48: 236-254. (Pubitemid 34107260)
18. Matsuzawa Y, Nakamura T, Takahashi M, et al. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992. (Pubitemid 35416333)
19. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol 1976; 103: 506-511.
20. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992; 3: 452-456.
21. Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005; 20: 575-579. (Pubitemid 41126030)
22. Knol MJ, VanderWeele TJ, Groenwold RH, Klungel OH, Rovers MM, Grobbee DE. Estimating measures of interaction on an additive scale for preventive exposures. Eur J Epidemiol 2011; 26: 433-438.
23. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004; 34: 9-19. (Pubitemid 40163989)